ABSTRACT
The purpose of this study was to evaluate whether group psychotherapy was effective in improving of quality of life and would decrease the symptoms of anxiety and depression in Parkinson's disease patients. Sixteen subjects, with idiopathic Parkinson's disease recruited from the school clinical Hospital/UNICAMP. Were randomly divided in to two groups, experimental and control. Parkinson's Disease and Quality of Life - PDQL; Beck Depression Inventory - BDI; State-Trait-Anxiety Inventory - STAI were used to evaluate the patients. The statistical analysis showed significant effect of the interaction group vs. time in depression (0.0009), anxiety (<0.0001) and QuoL (0.0018) and positive changes in depression (0.0029), anxiety (0.0009) and QuoL (0.0047) for the treated group.
Subject(s)
Cognitive Behavioral Therapy , Parkinson Disease/psychology , Quality of Life/psychology , Cognitive Behavioral Therapy/methods , Female , Humans , Male , Middle AgedABSTRACT
Este estudo descreve dados preliminares de eletromiografia laríngea (LEMG) e tratamento com toxina botulínica em pacientes com disfonia associada a distúrbios do movimento. Foram estudados 25 pacientes, 19 com distonia laríngea ou disfonia espasmódica, 5 com tremor vocal e 1 com síndrome de Gilles de la Tourette. LEMG realizada com eletrodos monopolares, antes da administração de toxina botulínica, foi compatível com distonia em 14 pacientes (normal em 5), sugeriu tremor essencial em 3 e Parkinson em 2. Os diferentes padrões de LEMG e melhora considerável obtida com administração de toxina botulínica instituíram LEMG como rotina no ambulatório de distúrbios do movimento da UNICAMP.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Botulinum Toxins/therapeutic use , Electromyography , Movement Disorders/diagnosis , Movement Disorders/drug therapy , Voice Disorders/diagnosis , Voice Disorders/drug therapy , Age Distribution , Botulinum Toxins/pharmacology , Elder Abuse , Larynx , Laryngeal Muscles/drug effects , Movement Disorders/complications , Sex Distribution , Voice Disorders/complicationsABSTRACT
This study describes preliminary laryngeal electromyography (LEMG) data and botulinum toxin treatment in patients with dysphonia due to movement disorders. Twenty-five patients who had been clinically selected for botulinum toxin administration were examined, 19 with suspected laryngeal dystonia or spasmodic dysphonia (SD), 5 with vocal tremor, and 1 with Gilles de la Tourette syndrome (GTS). LEMG evaluations were performed before botulinum toxin administration using monopolar electrodes. Electromyography was consistent with dystonia in 14 patients and normal in 5, and differences in frequency suggesting essential tremor in 3 and Parkinson tremors in 2. The different LEMG patterns and significant improvement in our patients from botulinum toxin therapy has led us to perform laryngeal electromyography as a routine in UNICAMP movement disorders ambulatory.
